It appears that CML LSCs are not completely reliant on BCR-ABL activity for survival so that these BCR-ABL-independent mechanisms may play a role in disease persistence [11]. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.